{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,14]],"date-time":"2026-10-14T12:00:02Z","timestamp":1791979202473,"version":"4.4.0"},"reference-count":50,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2021,10,1]],"date-time":"2021-10-01T00:00:00Z","timestamp":1633046400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2021,10,1]],"date-time":"2021-10-01T00:00:00Z","timestamp":1633046400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2021,10,1]],"date-time":"2021-10-01T00:00:00Z","timestamp":1633046400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2021,10,1]],"date-time":"2021-10-01T00:00:00Z","timestamp":1633046400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2021,10,1]],"date-time":"2021-10-01T00:00:00Z","timestamp":1633046400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2021,10,1]],"date-time":"2021-10-01T00:00:00Z","timestamp":1633046400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2021,10,1]],"date-time":"2021-10-01T00:00:00Z","timestamp":1633046400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100001700","name":"Ministry of Education, Culture, Sports, Science and Technology","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100001700","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100005845","name":"Hyogo College of Medicine","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100005845","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001691","name":"Japan Society for the Promotion of Science","doi-asserted-by":"publisher","award":["21K06591"],"award-info":[{"award-number":["21K06591"]}],"id":[{"id":"10.13039\/501100001691","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Pharmacology Biochemistry and Behavior"],"published-print":{"date-parts":[[2021,10]]},"DOI":"10.1016\/j.pbb.2021.173257","type":"journal-article","created":{"date-parts":[[2021,8,19]],"date-time":"2021-08-19T04:02:13Z","timestamp":1629345733000},"page":"173257","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":10,"special_numbering":"C","title":["Metoprine, a histamine N-methyltransferase inhibitor, attenuates methamphetamine-induced hyperlocomotion via activation of histaminergic neurotransmission in mice"],"prefix":"10.1016","volume":"209","author":[{"given":"Nobue","family":"Kitanaka","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"F. Scott","family":"Hall","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shotaro","family":"Kobori","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sota","family":"Kushihara","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hiroyuki","family":"Oyama","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yasuki","family":"Sasaoka","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Megumi","family":"Takechi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Koh-ichi","family":"Tanaka","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kazuo","family":"Tomita","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kento","family":"Igarashi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nobuyoshi","family":"Nishiyama","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tomoaki","family":"Sato","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"George R.","family":"Uhl","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Junichi","family":"Kitanaka","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.pbb.2021.173257_bb0005","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1016\/j.neulet.2013.07.026","article-title":"Histamine H3 receptor activation prevents dopamine D1 receptor-mediated inhibition of dopamine release in the rat striatum: a microdialysis study","volume":"552","author":"Alfaro-Rodriguez","year":"2013","journal-title":"Neurosci. Lett."},{"key":"10.1016\/j.pbb.2021.173257_bb0010","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1016\/j.neuropharm.2015.07.006","article-title":"Histamine H3 receptor activation inhibits dopamine synthesis but not release or uptake in rat nucleus accumbens","volume":"106","author":"Aquino-Miranda","year":"2016","journal-title":"Neuropharmacology"},{"key":"10.1016\/j.pbb.2021.173257_bb0015","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1016\/0006-2952(79)90500-8","article-title":"New inhibitors of histamine-N-methyltransferase","volume":"28","author":"Beaven","year":"1979","journal-title":"Biochem. Pharmacol."},{"key":"10.1016\/j.pbb.2021.173257_bb0020","doi-asserted-by":"crossref","first-page":"74","DOI":"10.1016\/j.neuropharm.2015.08.013","article-title":"Histamine and the striatum","volume":"106","author":"Bolam","year":"2016","journal-title":"Neuropharmacology"},{"key":"10.1016\/j.pbb.2021.173257_bb0025","doi-asserted-by":"crossref","first-page":"541","DOI":"10.1177\/0897190011426557","article-title":"Treatments for methamphetamine abuse: a literature review for the clinician","volume":"24","author":"Brackins","year":"2011","journal-title":"J. Pharm. Pract."},{"key":"10.1016\/j.pbb.2021.173257_bb0030","doi-asserted-by":"crossref","first-page":"329","DOI":"10.1016\/S0090-9556(25)06350-0","article-title":"Lipid-soluble inhibitors of dihydrofolate reductase. I. Kinetics, tissue distribution, and extent of metabolism of pyrimethamine, metoprine, and etoprine in the rat, dog, and man","volume":"6","author":"Cavallito","year":"1978","journal-title":"Drug Metab. Dispos."},{"key":"10.1016\/j.pbb.2021.173257_bb0035","doi-asserted-by":"crossref","first-page":"267","DOI":"10.1016\/S0740-5472(03)00028-X","article-title":"Treatment of methamphetamine abuse: research findings and clinical directions","volume":"24","author":"Cretzmeyer","year":"2003","journal-title":"J. Subst. Abus. Treat."},{"key":"10.1016\/j.pbb.2021.173257_bb0040","doi-asserted-by":"crossref","first-page":"1085","DOI":"10.1111\/j.1360-0443.2009.02564.x","article-title":"A review of the clinical pharmacology of methamphetamine","volume":"104","author":"Cruickshank","year":"2009","journal-title":"Addiction"},{"key":"10.1016\/j.pbb.2021.173257_bb0045","doi-asserted-by":"crossref","first-page":"951","DOI":"10.1016\/0091-3057(82)90478-6","article-title":"Dopaminergic properties of nomifensine","volume":"17","author":"Gianutsos","year":"1982","journal-title":"Pharmacol. Biochem. Behav."},{"key":"10.1016\/j.pbb.2021.173257_bb0050","first-page":"731","article-title":"Social and legal factors related to drug abuse in the United States and Japan","volume":"109","author":"Greberman","year":"1994","journal-title":"Public Health Rep."},{"key":"10.1016\/j.pbb.2021.173257_bb0055","doi-asserted-by":"crossref","first-page":"245","DOI":"10.1186\/s13643-020-01499-z","article-title":"Psychosocial and pharmacologic interventions for methamphetamine addiction: protocol for a scoping review of the literature","volume":"9","author":"Hamel","year":"2020","journal-title":"Syst. Rev."},{"key":"10.1016\/j.pbb.2021.173257_bb0060","doi-asserted-by":"crossref","first-page":"271","DOI":"10.1016\/S0022-3565(25)20964-8","article-title":"Effects of dopamine antagonists on neuronal histamine release in the striatum of rats subjected to acute and chronic treatments with methamphetamine","volume":"279","author":"Ito","year":"1996","journal-title":"J. Pharmacol. Exp. Ther."},{"key":"10.1016\/j.pbb.2021.173257_bb0065","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1111\/j.1440-1819.1997.tb02911.x","article-title":"The effect of methamphetamine on histamine release in the rat hypothalamus","volume":"51","author":"Ito","year":"1997","journal-title":"Psychiatry Clin. Neurosci."},{"key":"10.1016\/j.pbb.2021.173257_bb0070","doi-asserted-by":"crossref","first-page":"305","DOI":"10.1016\/0304-3940(84)90055-7","article-title":"Neuronal histamine inhibits methamphetamine-induced locomotor hyperactivity in mice","volume":"48","author":"Itoh","year":"1984","journal-title":"Neurosci. Lett."},{"key":"10.1016\/j.pbb.2021.173257_bb0075","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1196\/annals.1316.016","article-title":"Methamphetamine and brain histamine: a study using histamine-related gene knockout mice","volume":"1025","author":"Iwabuchi","year":"2004","journal-title":"Ann. N. Y. Acad. Sci."},{"key":"10.1016\/j.pbb.2021.173257_bb0080","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1016\/S0022-3565(25)33149-6","article-title":"Histamine-induced arousal in the conscious and pentobarbital-pretreated rat","volume":"222","author":"Kalivas","year":"1982","journal-title":"J. Pharmacol. Exp. Ther."},{"key":"10.1016\/j.pbb.2021.173257_bb0085","doi-asserted-by":"crossref","first-page":"578","DOI":"10.1111\/j.1365-2125.2010.03639.x","article-title":"Pharmacological approaches to methamphetamine dependence: a focused review","volume":"69","author":"Karila","year":"2010","journal-title":"Br. J. Clin. Pharmacol."},{"key":"10.1016\/j.pbb.2021.173257_bb0090","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1016\/S0014-2999(03)02015-6","article-title":"Behavioral sensitization and alteration in monoamine metabolism in mice after single versus repeated methamphetamine administration","volume":"474","author":"Kitanaka","year":"2003","journal-title":"Eur. J. Pharmacol."},{"key":"10.1016\/j.pbb.2021.173257_bb0095","doi-asserted-by":"crossref","first-page":"829","DOI":"10.1007\/s11064-006-9087-x","article-title":"Modification of morphine-induced hyperlocomotion and antinociception in mice by clorgyline, a monoamine oxidase-a inhibitor","volume":"31","author":"Kitanaka","year":"2006","journal-title":"Neurochem. Res."},{"key":"10.1016\/j.pbb.2021.173257_bb0100","doi-asserted-by":"crossref","first-page":"805","DOI":"10.1007\/s11064-006-9081-3","article-title":"Methamphetamine reward in mice as assessed by conditioned place preference test with supermex sensors: effect of subchronic clorgyline pretreatment","volume":"31","author":"Kitanaka","year":"2006","journal-title":"Neurochem. Res."},{"key":"10.1016\/j.pbb.2021.173257_bb0105","doi-asserted-by":"crossref","first-page":"765","DOI":"10.1016\/j.neuroscience.2007.05.006","article-title":"Blockade of brain histamine metabolism alters methamphetamine-induced expression pattern of stereotypy in mice via histamine H1 receptors","volume":"147","author":"Kitanaka","year":"2007","journal-title":"Neuroscience"},{"key":"10.1016\/j.pbb.2021.173257_bb0110","doi-asserted-by":"crossref","first-page":"464","DOI":"10.1016\/j.pbb.2009.10.009","article-title":"Pretreatment with L-histidine produces a shift from methamphetamine-induced stereotypical biting to persistent locomotion in mice","volume":"94","author":"Kitanaka","year":"2010","journal-title":"Pharmacol. Biochem. Behav."},{"key":"10.1016\/j.pbb.2021.173257_bb0115","doi-asserted-by":"crossref","first-page":"749","DOI":"10.1007\/s11064-010-0132-4","article-title":"Withdrawal from fixed-dose injection of methamphetamine decreases cerebral levels of 3-methoxy-4-hydroxyphenylglycol and induces the expression of anxiety-related behavior in mice","volume":"35","author":"Kitanaka","year":"2010","journal-title":"Neurochem. Res."},{"key":"10.1016\/j.pbb.2021.173257_bb0120","doi-asserted-by":"crossref","first-page":"1824","DOI":"10.1007\/s11064-011-0500-8","article-title":"Histamine H3 receptor agonists decrease hypothalamic histamine levels and increase stereotypical biting in mice challenged with methamphetamine","volume":"36","author":"Kitanaka","year":"2011","journal-title":"Neurochem. Res."},{"key":"10.1016\/j.pbb.2021.173257_bb0125","doi-asserted-by":"crossref","first-page":"11","DOI":"10.4137\/JEN.S10046","article-title":"Attenuation of methamphetamine-induced conditioned place preference in mice after a drug-free period and facilitation of this effect by exposure to a running wheel","volume":"6","author":"Kitanaka","year":"2012","journal-title":"J. Exp. Neurosci."},{"key":"10.1016\/j.pbb.2021.173257_bb0130","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1016\/j.brainres.2011.10.037","article-title":"A single administration of methamphetamine to mice early in the light period decreases running wheel activity observed during the dark period","volume":"1429","author":"Kitanaka","year":"2012","journal-title":"Brain Res."},{"key":"10.1016\/j.pbb.2021.173257_bb0135","doi-asserted-by":"crossref","first-page":"1","DOI":"10.4137\/DTI.S38342","article-title":"Brain histamine N-methyltransferase as a possible target of treatment for methamphetamine overdose","volume":"10","author":"Kitanaka","year":"2016","journal-title":"Drug Target Insights"},{"key":"10.1016\/j.pbb.2021.173257_bb0140","doi-asserted-by":"crossref","first-page":"16","DOI":"10.17352\/2455-3484.000021","article-title":"How the histamine N-methyltransferase inhibitor metoprine alleviates methamphetamine reward","volume":"3","author":"Kitanaka","year":"2017","journal-title":"J .Addict. Med. Ther. Sci."},{"key":"10.1016\/j.pbb.2021.173257_bb0145","doi-asserted-by":"crossref","DOI":"10.1016\/j.brainres.2020.146873","article-title":"In vivo evaluation of effects of histamine H3 receptor antagonists on methamphetamine-induced hyperlocomotion in mice","volume":"1740","author":"Kitanaka","year":"2020","journal-title":"Brain Res."},{"key":"10.1016\/j.pbb.2021.173257_bb0150","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1159\/000125005","article-title":"Histaminergic regulation of prolactin secretion: involvement of tuberoinfundibular dopaminergic neurons","volume":"48","author":"Knigge","year":"1988","journal-title":"Neuroendocrinology"},{"key":"10.1016\/j.pbb.2021.173257_bb0155","doi-asserted-by":"crossref","first-page":"837","DOI":"10.1046\/j.1471-4159.2002.01189.x","article-title":"Increased methamphetamine-induced locomotor activity and behavioral sensitization in histamine-deficient mice","volume":"83","author":"Kubota","year":"2002","journal-title":"J. Neurochem."},{"key":"10.1016\/j.pbb.2021.173257_bb0160","doi-asserted-by":"crossref","first-page":"1331","DOI":"10.1038\/sj.bjp.0701740","article-title":"Antidepressant-like effects of endogenous histamine and of two histamine H1 receptor agonists in the mouse forced swim test","volume":"123","author":"Lamberti","year":"1998","journal-title":"Br. J. Pharmacol."},{"key":"10.1016\/j.pbb.2021.173257_bb0165","first-page":"291","article-title":"Effect of L-histidine pretreatment on methamphetamine induced sterotyped behaviour in rats","volume":"23","author":"Muley","year":"1979","journal-title":"Indian J. Physiol. Pharmacol."},{"key":"10.1016\/j.pbb.2021.173257_bb0170","doi-asserted-by":"crossref","first-page":"967","DOI":"10.1016\/S0022-3565(25)23207-4","article-title":"Effect of reserpine on histamine metabolism in the mouse brain","volume":"256","author":"Muroi","year":"1991","journal-title":"J. Pharmacol. Exp. Ther."},{"key":"10.1016\/j.pbb.2021.173257_bb0175","doi-asserted-by":"crossref","first-page":"227","DOI":"10.1080\/00223989809599162","article-title":"Psychophysiological aspects of amphetamine-methamphetamine abuse","volume":"132","author":"Murray","year":"1998","journal-title":"J. Psychol."},{"key":"10.1016\/j.pbb.2021.173257_bb0180","series-title":"NIDA DrugFacts: Methamphetamine","year":"2014"},{"key":"10.1016\/j.pbb.2021.173257_bb0185","first-page":"559","article-title":"Lipid-soluble diaminopyrimidine inhibitors of dihydrofolate reductase","volume":"61","author":"Nichol","year":"1977","journal-title":"Cancer Treat. Rep."},{"key":"10.1016\/j.pbb.2021.173257_bb0190","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1254\/jphs.09024FP","article-title":"Methamphetamine- and 3,4-methylenedioxymethamphetamine-induced behavioral changes in histamine H3-receptor knockout mice","volume":"111","author":"Okuda","year":"2009","journal-title":"J. Pharmacol. Sci."},{"key":"10.1016\/j.pbb.2021.173257_bb0195","doi-asserted-by":"crossref","first-page":"116","DOI":"10.1007\/BF00517307","article-title":"In vivo release by histamine agonists and antagonists of endogenous catecholamines in the cat hypothalamus","volume":"326","author":"Philippu","year":"1984","journal-title":"Naunyn Schmiedeberg's Arch. Pharmacol."},{"key":"10.1016\/j.pbb.2021.173257_bb0200","doi-asserted-by":"crossref","first-page":"301","DOI":"10.1007\/BF00167449","article-title":"Modulation by dopamine receptors of the histamine release in the rat hypothalamus","volume":"347","author":"Prast","year":"1993","journal-title":"Naunyn Schmiedeberg's Arch. Pharmacol."},{"key":"10.1016\/j.pbb.2021.173257_bb0205","doi-asserted-by":"crossref","first-page":"397","DOI":"10.1016\/0024-3205(92)90406-F","article-title":"Effects of (S)-alpha -fluoromethylhistidine and metoprine on locomotor activity and brain histamine content in mice","volume":"51","author":"Sakai","year":"1992","journal-title":"Life Sci."},{"key":"10.1016\/j.pbb.2021.173257_bb0210","doi-asserted-by":"crossref","first-page":"148","DOI":"10.1016\/j.eplepsyres.2012.03.016","article-title":"Metoprine induced behavioral modifications and brain regional histamine increase in WAG\/Rij and wistar rats","volume":"101","author":"Samotaeva","year":"2012","journal-title":"Epilepsy Res."},{"key":"10.1016\/j.pbb.2021.173257_bb0215","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1016\/bs.irn.2015.02.003","article-title":"Neurologic complications of psychomotor stimulant abuse","volume":"120","author":"Sanchez-Ramos","year":"2015","journal-title":"Int. Rev. Neurobiol."},{"key":"10.1016\/j.pbb.2021.173257_bb0220","doi-asserted-by":"crossref","first-page":"160","DOI":"10.1111\/j.1749-6632.1992.tb25965.x","article-title":"A lasting vulnerability to psychosis in patients with previous methamphetamine psychosis","volume":"654","author":"Sato","year":"1992","journal-title":"Ann. N. Y. Acad. Sci."},{"key":"10.1016\/j.pbb.2021.173257_bb0225","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1007\/BF01244933","article-title":"Histamine inhibits dopamine release in the mouse striatum via presynaptic H3 receptors","volume":"93","author":"Schlicker","year":"1993","journal-title":"J. Neural Transm. Gen. Sect."},{"key":"10.1016\/j.pbb.2021.173257_bb0230","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1016\/S0074-7742(09)85008-3","article-title":"Roles of the histaminergic neurotransmission on methamphetamine-induced locomotor sensitization and reward: a study of receptors gene knockout mice","volume":"85","author":"Takino","year":"2009","journal-title":"Int. Rev. Neurobiol."},{"key":"10.1016\/j.pbb.2021.173257_bb0235","doi-asserted-by":"crossref","first-page":"1359","DOI":"10.1007\/s11064-006-9180-1","article-title":"Lobeline attenuates methamphetamine-induced stereotypy in adolescent mice","volume":"31","author":"Tatsuta","year":"2006","journal-title":"Neurochem. Res."},{"key":"10.1016\/j.pbb.2021.173257_bb0240","doi-asserted-by":"crossref","first-page":"279","DOI":"10.1196\/annals.1316.035","article-title":"Clinical features of sensitization to methamphetamine observed in patients with methamphetamine dependence and psychosis","volume":"1025","author":"Ujike","year":"2004","journal-title":"Ann. N. Y. Acad. Sci."},{"key":"10.1016\/j.pbb.2021.173257_bb0245","first-page":"821","article-title":"Changes in the rat brain histamine content following metoprine and other histamine-methyltransferase (HMT) inhibitors","volume":"37","author":"Zawilska","year":"1985","journal-title":"Pol. J. Pharmacol. Pharm."},{"key":"10.1016\/j.pbb.2021.173257_bb0250","doi-asserted-by":"crossref","DOI":"10.1016\/j.physbeh.2019.112649","article-title":"Effects of moderate- and high-intensity acute aerobic exercise on food reward and appetite in individuals with methamphetamine dependence","volume":"211","author":"Zhou","year":"2019","journal-title":"Physiol. Behav."}],"container-title":["Pharmacology Biochemistry and Behavior"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0091305721001568?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0091305721001568?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,25]],"date-time":"2025-09-25T04:41:07Z","timestamp":1758775267000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0091305721001568"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,10]]},"references-count":50,"alternative-id":["S0091305721001568"],"URL":"https:\/\/doi.org\/10.1016\/j.pbb.2021.173257","relation":{},"ISSN":["0091-3057"],"issn-type":[{"value":"0091-3057","type":"print"}],"subject":[],"published":{"date-parts":[[2021,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Metoprine, a histamine N-methyltransferase inhibitor, attenuates methamphetamine-induced hyperlocomotion via activation of histaminergic neurotransmission in mice","name":"articletitle","label":"Article Title"},{"value":"Pharmacology Biochemistry and Behavior","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.pbb.2021.173257","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2021 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"173257"}}